The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hendricks, R. L.
Right arrow Articles by Finnegan, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hendricks, R. L.
Right arrow Articles by Finnegan, A.

The Journal of Immunology, Vol 149, Issue 9 3023-3028, Copyright © 1992 by American Association of Immunologists

ARTICLES

IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice

RL Hendricks, TM Tumpey and A Finnegan
Department of Ophthalmology and Visual Sciences, University of Illinois, Chicago 60612.

HSV type 1 (HSV-1) infection of the mouse cornea results in a tissue- destructive inflammatory reaction in the cornea, but little or no disease in the skin surrounding the eye. Depleting T lymphocytes from mice before HSV-1 corneal infection prevents the corneal inflammation but severely exacerbates the periocular skin lesions. Studies described in this communication investigated the role of T cell cytokines in the corneal and periocular skin disease induced by HSV-1 corneal infection. Mice received weekly i.p. injections of rat mAb specific for IL-2, IL- 4, or IFN-gamma beginning 1 day before (day -1) or 6 days after (day +6) corneal infection with the RE strain of HSV-1. The severity of corneal inflammation and the area of periocular skin involvement were measured. Treatment with anti-IFN-gamma or anti-IL-2 significantly reduced the incidence and severity of corneal inflammation. Treatment was equally effective when initiated on day -1 (before T cell activation) or day +6 (after T cell activation but before the initiation of corneal inflammation). Treatment with anti-IL-4 had no effect. The histologic features of corneal inflammation in mock-treated mice included neovascularization, corneal edema, and cellular infiltration. Corneas of anti-IL-2-treated mice that developed inflammation had similar but less severe histologic features. Corneas of anti-IFN-gamma-treated mice that developed inflammation had neovascularization and edema but minimal cellular infiltration. Treatment with anti-IFN-gamma or anti-IL-2 significantly exacerbated periocular skin lesions when initiated at day -1, but not when initiated at day +6. Anti-IL-4 treatment had no effect on skin lesions. Treatment with either anti-IFN-gamma or anti-IL-2, when initiated at day -1, significantly inhibited the delayed-type hypersensitivity response to HSV Ag, but when treatment was begun at day +6 only anti- IFN-gamma significantly inhibited the delayed-type hypersensitivity response. Our findings suggest that IFN-gamma and IL-2 are important elements in both an immunopathologic T-lymphocyte response to HSV-1 Ag in the cornea and a protective T lymphocyte response in the skin.


This article has been cited by other articles:


Home page
 J. Virol.Home page
A. A. Chentoufi, N. R. Binder, N. Berka, G. Durand, A. Nguyen, I. Bettahi, B. Maillere, and L. BenMohamed
Asymptomatic Human CD4+ Cytotoxic T-Cell Epitopes Identified from Herpes Simplex Virus Glycoprotein B
J. Virol., December 1, 2008; 82(23): 11792 - 11802.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. P. Marques, M. C-J. Cheeran, J. M. Palmquist, S. Hu, S. L. Urban, and J. R. Lokensgard
Prolonged Microglial Cell Activation and Lymphocyte Infiltration following Experimental Herpes Encephalitis
J. Immunol., November 1, 2008; 181(9): 6417 - 6426.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
P. S. Bhattacharjee, D. M. Neumann, T. P. Foster, C. Clement, G. Singh, H. W. Thompson, H. E. Kaufman, and J. M. Hill
Effective Treatment of Ocular HSK with a Human Apolipoprotein E Mimetic Peptide in a Mouse Eye Model
Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4263 - 4268.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. J. Divito and R. L. Hendricks
Activated Inflammatory Infiltrate in HSV-1-Infected Corneas without Herpes Stromal Keratitis
Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1488 - 1495.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. A. Austin, W. P. Halford, B. R. G. Williams, and D. J. J. Carr
Oligoadenylate Synthetase/Protein Kinase R Pathways and {alpha}beta TCR+ T Cells Are Required for Adenovirus Vector: IFN-{gamma} Inhibition of Herpes Simplex Virus-1 in Cornea
J. Immunol., April 15, 2007; 178(8): 5166 - 5172.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
A. J. Lepisto, M. Xu, H. Yagita, A. D. Weinberg, and R. L. Hendricks
Expression and function of the OX40/OX40L costimulatory pair during herpes stromal keratitis
J. Leukoc. Biol., March 1, 2007; 81(3): 766 - 774.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. J. Lepisto, G. M. Frank, M. Xu, P. M. Stuart, and R. L. Hendricks
CD8 T Cells Mediate Transient Herpes Stromal Keratitis in CD4-Deficient Mice.
Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3400 - 3409.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. A. McClellan, X. Huang, R. P. Barrett, S. Lighvani, Y. Zhang, D. Richiert, and L. D. Hazlett
Matrix Metalloproteinase-9 Amplifies the Immune Response to Pseudomonas aeruginosa Corneal Infection
Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 256 - 264.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. Heiligenhaus, H. F. Li, Y. Yang, S. Wasmuth, K. P. Steuhl, and D. Bauer
Transplantation of Amniotic Membrane in Murine Herpes Stromal Keratitis Modulates Matrix Metalloproteinases in the Cornea
Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4079 - 4085.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Xu, A. J. Lepisto, and R. L. Hendricks
CD154 Signaling Regulates the Th1 Response to Herpes Simplex Virus-1 and Inflammation in Infected Corneas
J. Immunol., July 15, 2004; 173(2): 1232 - 1239.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Al-khatib, B. R. G. Williams, R. H. Silverman, W. Halford, and D. J. J. Carr
Distinctive Roles for 2',5'-Oligoadenylate Synthetases and Double-Stranded RNA-Dependent Protein Kinase R in the In Vivo Antiviral Effect of an Adenoviral Vector Expressing Murine IFN-{beta}
J. Immunol., May 1, 2004; 172(9): 5638 - 5647.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
N. Awasthi and B. J. Wagner
Interferon-{gamma} Induces Apoptosis of Lens {alpha}TN4-1 Cells and Proteasome Inhibition Has an Antiapoptotic Effect
Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 222 - 229.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
D. J. J. Carr, J. Chodosh, J. Ash, and T. E. Lane
Effect of Anti-CXCL10 Monoclonal Antibody on Herpes Simplex Virus Type 1 Keratitis and Retinal Infection
J. Virol., September 15, 2003; 77(18): 10037 - 10046.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
L. BenMohamed, G. Bertrand, C. D. McNamara, H. Gras-Masse, J. Hammer, S. L. Wechsler, and A. B. Nesburn
Identification of Novel Immunodominant CD4+ Th1-Type T-Cell Peptide Epitopes from Herpes Simplex Virus Glycoprotein D That Confer Protective Immunity
J. Virol., September 1, 2003; 77(17): 9463 - 9473.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
C. Jones
Herpes Simplex Virus Type 1 and Bovine Herpesvirus 1 Latency
Clin. Microbiol. Rev., January 1, 2003; 16(1): 79 - 95.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Maertzdorf, A. D. M. E. Osterhaus, and G. M. G. M. Verjans
IL-17 Expression in Human Herpetic Stromal Keratitis: Modulatory Effects on Chemokine Production by Corneal Fibroblasts
J. Immunol., November 15, 2002; 169(10): 5897 - 5903.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
H. Ghiasi, Y. Osorio, G.-C. Perng, A. B. Nesburn, and S. L. Wechsler
Overexpression of Interleukin-2 by a Recombinant Herpes Simplex Virus Type 1 Attenuates Pathogenicity and Enhances Antiviral Immunity
J. Virol., August 12, 2002; 76(18): 9069 - 9078.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
D. J. J. Carr and S. Noisakran
The Antiviral Efficacy of the Murine Alpha-1 Interferon Transgene against Ocular Herpes Simplex Virus Type 1 Requires the Presence of CD4+, {alpha}/{beta} T-Cell Receptor-Positive T Lymphocytes with the Capacity To Produce Gamma Interferon
J. Virol., August 12, 2002; 76(18): 9398 - 9406.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
T. H. Stumpf, R. Case, C. Shimeld, D. L. Easty, and T. J. Hill
Primary herpes simplex virus type 1 infection of the eye triggers similar immune responses in the cornea and the skin of the eyelids
J. Gen. Virol., June 1, 2002; 83(7): 1579 - 1590.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
T. L. Keadle, L. A. Morrison, J. L. Morris, J. S. Pepose, and P. M. Stuart
Therapeutic Immunization with a Virion Host Shutoff-Defective, Replication-Incompetent Herpes Simplex Virus Type 1 Strain Limits Recurrent Herpetic Ocular Infection
J. Virol., March 19, 2002; 76(8): 3615 - 3625.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
S. Lee, M. Zheng, S. Deshpande, S. K. Eo, T. A. Hamilton, and B. T. Rouse
IL-12 suppresses the expression of ocular immunoinflammatory lesions by effects on angiogenesis
J. Leukoc. Biol., March 1, 2002; 71(3): 469 - 476.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
K. A. Kernacki, R. P Barrett, S. McClellan, and L. D. Hazlett
MIP-1{alpha} regulates CD4+ T cell chemotaxis and indirectly enhances PMN persistence in Pseudomonas aeruginosa corneal infection
J. Leukoc. Biol., December 1, 2001; 70(6): 911 - 919.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
D. J.J. Carr, P. Härle, and B. M. Gebhardt
The Immune Response to Ocular Herpes Simplex Virus Type 1 Infection
Experimental Biology and Medicine, May 1, 2001; 226(5): 353 - 366.
[Abstract] [Full Text]

Home page
 J. Virol.Home page
X. Han, P. Lundberg, B. Tanamachi, H. Openshaw, J. Longmate, and E. Cantin
Gender Influences Herpes Simplex Virus Type 1 Infection in Normal and Gamma Interferon-Mutant Mice
J. Virol., March 15, 2001; 75(6): 3048 - 3052.
[Abstract] [Full Text]

Home page
 IOVSHome page
T. H. Stumpf, C. Shimeld, D. L. Easty, and T. J. Hill
Cytokine Production in a Murine Model of Recurrent Herpetic Stromal Keratitis
Invest. Ophthalmol. Vis. Sci., February 1, 2001; 42(2): 372 - 378.
[Abstract] [Full Text]

Home page
 J. Virol.Home page
E. Chang, L. Galle, D. Maggs, D. M. Estes, and W. J. Mitchell
Pathogenesis of Herpes Simplex Virus Type 1-Induced Corneal Inflammation in Perforin-Deficient Mice
J. Virol., December 15, 2000; 74(24): 11832 - 11840.
[Abstract] [Full Text]

Home page
 J. Virol.Home page
D. M. Koelle, S. N. Reymond, H. Chen, W. W. Kwok, C. McClurkan, T. Gyaltsong, E. W. Petersdorf, W. Rotkis, A. R. Talley, and D. A. Harrison
Tegument-Specific, Virus-Reactive CD4 T Cells Localize to the Cornea in Herpes Simplex Virus Interstitial Keratitis in Humans
J. Virol., December 1, 2000; 74(23): 10930 - 10938.
[Abstract] [Full Text]

Home page
 J. Gen. Virol.Home page
D. F. Westra, G. M. G. M. Verjans, A. D. M. E. Osterhaus, A. van Kooij, G. W. Welling, A. J. Scheffer, T. H. The, and S. Welling-Wester
Natural infection with herpes simplex virus type 1 (HSV-1) induces humoral and T cell responses to the HSV-1 glycoprotein H:L complex
J. Gen. Virol., August 1, 2000; 81(8): 2011 - 2015.
[Abstract] [Full Text]

Home page
 IOVSHome page
G. M. G. M. Verjans, L. Remeijer, C. M. Mooy, and A. D. M. E. Osterhaus
Herpes Simplex Virus-Specific T Cells Infiltrate the Cornea of Patients with Herpetic Stromal Keratitis: No Evidence for Autoreactive T Cells
Invest. Ophthalmol. Vis. Sci., August 1, 2000; 41(9): 2607 - 2612.
[Abstract] [Full Text]

Home page
 J. Virol.Home page
S. P. Deshpande, M. Zheng, M. Daheshia, and B. T. Rouse
Pathogenesis of Herpes Simplex Virus-Induced Ocular Immunoinflammatory Lesions in B-Cell-Deficient Mice
J. Virol., April 15, 2000; 74(8): 3517 - 3524.
[Abstract] [Full Text]

Home page
 J. Virol.Home page
T. J. Smith, C. E. Ackland-Berglund, and D. A. Leib
Herpes Simplex Virus Virion Host Shutoff (vhs) Activity Alters Periocular Disease in Mice
J. Virol., April 15, 2000; 74(8): 3598 - 3604.
[Abstract] [Full Text]

Home page
 IOVSHome page
S. Gangappa, S. P. Deshpande, and B. T. Rouse
Bystander Activation of CD4+ T Cells Accounts for Herpetic Ocular Lesions
Invest. Ophthalmol. Vis. Sci., February 1, 2000; 41(2): 453 - 459.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
K. A. Kernacki, R. P. Barrett, J. A. Hobden, and L. D. Hazlett
Macrophage Inflammatory Protein-2 Is a Mediator of Polymorphonuclear Neutrophil Influx in Ocular Bacterial Infection
J. Immunol., January 15, 2000; 164(2): 1037 - 1045.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
K. A. Kernacki, R. Barrett, and L. D. Hazlett
Evidence for TIMP-1 Protection Against P. aeruginosa-Induced Corneal Ulceration and Perforation
Invest. Ophthalmol. Vis. Sci., December 1, 1999; 40(13): 3168 - 3176.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
D. J. Maggs, E. Chang, M. P. Nasisse, and W. J. Mitchell
Persistence of Herpes Simplex Virus Type 1 DNA in Chronic Conjunctival and Eyelid Lesions of Mice
J. Virol., November 1, 1998; 72(11): 9166 - 9172.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Gangappa, J. S. Babu, J. Thomas, M. Daheshia, and B. T. Rouse
Virus-Induced Immunoinflammatory Lesions in the Absence of Viral Antigen Recognition
J. Immunol., October 15, 1998; 161(8): 4289 - 4300.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. Chun, M. Daheshia, N. A. Kuklin, and B. T. Rouse
Modulation of Viral Immunoinflammatory Responses with Cytokine DNA Administered by Different Routes
J. Virol., July 1, 1998; 72(7): 5545 - 5551.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Chen and R. L. Hendricks
B7 Costimulatory Requirements of T Cells at an Inflammatory Site
J. Immunol., May 15, 1998; 160(10): 5045 - 5052.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
T. M. Tumpey, H. Cheng, D. N. Cook, O. Smithies, J. E. Oakes, and R. N. Lausch
Absence of Macrophage Inflammatory Protein-1alpha Prevents the Development of Blinding Herpes Stromal Keratitis
J. Virol., May 1, 1998; 72(5): 3705 - 3710.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Thomas and B. T. Rouse
Immunopathology of Herpetic Stromal Keratitis: Discordance in CD4+ T Cell Function Between Euthymic Host and Reconstituted SCID Recipients
J. Immunol., April 15, 1998; 160(8): 3965 - 3970.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
K. Goldsmith, W. Chen, D. C. Johnson, and R. L. Hendricks
Infected Cell Protein (ICP)47 Enhances Herpes Simplex Virus Neurovirulence by Blocking the CD8+ T Cell Response
J. Exp. Med., February 2, 1998; 187(3): 341 - 348.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
R. Sciammas, P. Kodukula, Q. Tang, R.L. Hendricks, and J.A. Bluestone
T Cell Receptor-gamma /delta Cells Protect Mice from Herpes Simplex Virus Type 1-induced Lethal Encephalitis
J. Exp. Med., June 2, 1997; 185(11): 1969 - 1975.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1992 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1992 by The American Association of Immunologists, Inc. All rights reserved.